Cernostics: TissueCypher Accurately Predicts Progression to Esophageal Cancer in Patients with Barrett's Esophagus
Cernostics' TissueCypher Barrett's Esophagus Assay was able to identify non-dysplastic Barrett's esophagus patients at high risk for progression to cancer who are missed by current standard of care.
Read full article »
Cernostics is a provider of tissue-based cancer diagnostics and prognostics test solutions.
Read more